Current and emerging strategies to combat antimalarial resistance.
Plasmodium falciparum
antimalarial
drug efficacy
drug resistance
malaria
selection pressure
Journal
Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
pubmed:
6
8
2021
medline:
22
4
2022
entrez:
5
8
2021
Statut:
ppublish
Résumé
Since the spread of chloroquine resistance in We reviewed past recommendations and activities to respond to resistance as well as ongoing research into new ways to stop or delay the spread of resistant parasites. Inadequate information limits the options and support for a strong, coordinated response to artemisinin partial resistance in Africa, making better phenotypic and genotypic surveillance a priority. A response to resistance needs to address factors that may have hastened the emergence and could speed the spread, including overuse of drugs and lack of access to quality treatment. New ways to use the existing treatments in response to resistance, such as multiple first-lines, are currently impeded by the limited number of drugs available.
Identifiants
pubmed: 34348573
doi: 10.1080/14787210.2021.1962291
doi:
Substances chimiques
Antimalarials
0
Folic Acid Antagonists
0
Chloroquine
886U3H6UFF
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
353-372Subventions
Organisme : World Health Organization
ID : 001
Pays : International